Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 105,309,592
  • Shares Outstanding, K 258,308
  • Annual Sales, $ 9,869 M
  • Annual Income, $ 3,620 M
  • 60-Month Beta 0.35
  • Price/Sales 10.70
  • Price/Cash Flow 27.89
  • Price/Book 5.99
Trade VRTX with:

Options Overview Details

View History
  • Implied Volatility 25.77% ( +0.08%)
  • Historical Volatility 19.51%
  • IV Percentile 54%
  • IV Rank 48.49%
  • IV High 34.35% on 01/16/24
  • IV Low 17.69% on 12/26/23
  • Put/Call Vol Ratio 0.73
  • Today's Volume 3,810
  • Volume Avg (30-Day) 1,596
  • Put/Call OI Ratio 1.01
  • Today's Open Interest 40,132
  • Open Int (30-Day) 44,478

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 3.61
  • Number of Estimates 11
  • High Estimate 4.01
  • Low Estimate 2.94
  • Prior Year 2.67
  • Growth Rate Est. (year over year) +35.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
406.97 +1.08%
on 03/15/24
437.00 -5.86%
on 02/27/24
-10.82 (-2.56%)
since 02/16/24
3-Month
395.01 +4.14%
on 12/19/23
448.40 -8.26%
on 01/30/24
+6.73 (+1.66%)
since 12/18/23
52-Week
296.09 +38.94%
on 03/20/23
448.40 -8.26%
on 01/30/24
+115.61 (+39.09%)
since 03/17/23

Most Recent Stories

More News
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

It's always a good time to buy great stocks with excellent prospects.

VRTX : 411.38 (+0.91%)
HCA : 327.17 (+1.62%)
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

There's no need for delays in buying these great stocks.

LLY : 762.66 (+1.13%)
NVO : 132.89 (+0.39%)
VRTX : 411.38 (+0.91%)
Forget Tesla, Buy This Magnificent Healthcare Stock Instead

Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future.

TSLA : 173.80 (+6.25%)
VRTX : 411.38 (+0.91%)
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.

Good news could be in store for all three of these drugmakers.

LLY : 762.66 (+1.13%)
MDGL : 283.23 (+4.76%)
REGN : 959.92 (-0.47%)
VRTX : 411.38 (+0.91%)
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market

All three have exciting programs on the way.

VRTX : 411.38 (+0.91%)
CMPS : 9.79 (-1.11%)
CPRX : 16.08 (+0.06%)
Why Editas Medicine Stock Soared as Much as 42% Higher This Week

The clinical-stage genome editing company dropped a couple of important announcements for shareholders.

VRTX : 411.38 (+0.91%)
C : 58.63 (+1.77%)
EDIT : 7.72 (-5.04%)
3 Magnificent Growth Stocks to Buy in March

These three stocks have two important common denominators: the same industry and tremendous growth prospects.

MRK : 121.44 (-0.07%)
MS : 87.96 (-0.48%)
NVO : 132.89 (+0.39%)
LLY : 762.66 (+1.13%)
MRNA : 104.26 (+0.39%)
VRTX : 411.38 (+0.91%)
These 4 Stocks Are the "Magnificent Seven" of Healthcare

Their growth trajectories aren't as meteoric, but they're still notable.

NVDA : 884.55 (+0.70%)
AAPL : 173.72 (+0.64%)
MSFT : 417.32 (+0.22%)
LLY : 762.66 (+1.13%)
NVO : 132.89 (+0.39%)
VRTX : 411.38 (+0.91%)
ISRG : 392.62 (-0.92%)
Could These 3 Companies Headline a "Magnificent Seven" of Biotech Stocks?

These stocks meet many of the criteria long-term investors look for.

VRTX : 411.38 (+0.91%)
LLY : 762.66 (+1.13%)
NVO : 132.89 (+0.39%)
Vertex Pharmaceuticals (VRTX) Should Remain Supported

Vertex Pharmaceuticals Incorporated (VRTX) , is a biotechnology company. It engages in developing & commercializing therapies for treating cystic fibrosis (CF). The company has collaborations with CRISPR...

VRTX : 411.38 (+0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 421.09
2nd Resistance Point 418.30
1st Resistance Point 414.84
Last Price 411.38
1st Support Level 408.58
2nd Support Level 405.79
3rd Support Level 402.33

See More

52-Week High 448.40
Last Price 411.38
Fibonacci 61.8% 390.22
Fibonacci 50% 372.24
Fibonacci 38.2% 354.27
52-Week Low 296.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar